|
|
|
Insider
Information: |
Kirk Randal J |
Relationship: |
10% Owner |
City: |
Radford |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
3,684,697 |
|
Indirect Shares
|
67,796,291 |
|
|
Direct
Value |
$162,038,028 |
|
|
Indirect Value
|
$374,282,250 |
|
|
Total
Shares |
71,480,988 |
|
|
Total
Value |
$536,320,277 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
0
|
Stock
price went up :
|
6
|
0
|
Stock
price went down : |
8
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
46.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-09 |
4 |
S |
$17.48 |
$3,900,260 |
I/I |
(223,127) |
3,396,879 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-10 |
4 |
S |
$17.08 |
$3,466,540 |
I/I |
(202,959) |
3,276,273 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-14 |
4 |
S |
$17.36 |
$5,262,996 |
I/I |
(303,168) |
3,096,119 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-15 |
4 |
S |
$17.15 |
$1,569,928 |
I/I |
(91,541) |
3,041,722 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-16 |
4 |
S |
$17.24 |
$1,644,058 |
I/I |
(95,363) |
2,985,054 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-21 |
4 |
S |
$17.15 |
$2,765,369 |
I/I |
(161,246) |
2,894,871 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-22 |
4 |
S |
$17.49 |
$13,675,099 |
I/I |
(781,881) |
2,430,247 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-23 |
4 |
S |
$18.48 |
$4,644,671 |
I/I |
(251,335) |
2,280,894 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-24 |
4 |
S |
$18.20 |
$1,881,370 |
I/I |
(103,372) |
2,219,466 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-27 |
4 |
S |
$18.22 |
$1,992,849 |
I/I |
(109,377) |
2,154,470 |
0 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2018-08-28 |
4 |
S |
$0.41 |
$10,086 |
I/I |
(24,600) |
27,151 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-28 |
4 |
S |
$18.02 |
$7,789,127 |
I/I |
(432,249) |
1,897,610 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2018-08-31 |
4 |
A |
$13.74 |
$999,984 |
I/I |
71,227 |
15,963,964 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2018-09-28 |
4 |
A |
$14.31 |
$999,979 |
I/I |
67,518 |
15,975,578 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2018-10-31 |
4 |
A |
$11.56 |
$999,992 |
I/I |
72,779 |
15,992,879 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2018-11-20 |
4 |
A |
$0.00 |
$0 |
I/I |
396,668 |
83,221 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2018-11-30 |
4 |
A |
$0.00 |
$0 |
I/I |
98,002 |
16,013,287 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2018-12-31 |
4 |
A |
$6.54 |
$999,993 |
I/I |
127,082 |
16,043,868 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-01-04 |
4 |
A |
$0.00 |
$0 |
I/I |
13,774 |
16,057,642 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-01-31 |
4 |
A |
$7.66 |
$199,995 |
I/I |
26,109 |
16,083,751 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-02-28 |
4 |
A |
$7.97 |
$199,999 |
I/I |
25,094 |
16,108,845 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-03-29 |
4 |
A |
$5.26 |
$199,996 |
I/I |
38,022 |
16,146,867 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-04-30 |
4 |
A |
$4.56 |
$200,125 |
I/I |
43,887 |
16,190,754 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
508,617 |
2,091,141 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-05-17 |
4 |
B |
$4.69 |
$283,886 |
I/I |
60,530 |
858,125 |
2.64 |
- |
|
271 Records found
|
|
Page 8 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|